SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018757
Filing Date
2018-08-02
Accepted
2018-08-02 11:37:02
Documents
66
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-10q_20180630.htm 10-Q 2228334
2 EX-31.1 mcrb-ex311_6.htm EX-31.1 11509
3 EX-31.2 mcrb-ex312_9.htm EX-31.2 11486
4 EX-32.1 mcrb-ex321_8.htm EX-32.1 7642
5 EX-32.2 mcrb-ex322_7.htm EX-32.2 7681
  Complete submission text file 0001564590-18-018757.txt   7387763

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mcrb-20180630.xml EX-101.INS 1780793
7 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20180630.xsd EX-101.SCH 39957
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20180630_cal.xml EX-101.CAL 38063
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20180630_def.xml EX-101.DEF 142707
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20180630_lab.xml EX-101.LAB 297529
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20180630_pre.xml EX-101.PRE 261339
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 18987207
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences